Articles tagged with "GW Pharmaceuticals"
5 total articles - Page 1 of 1
DEA loosens rules on prescription CBD drug EpidiolexDavid Downs - Published on April 6, 2020Read more
Prescription CBD tincture Epidiolex is coming to more patients. Cost: $32,500 per year.
What’s Next for Epidiolex Maker GW PharmaceuticalsBen Adlin - Published on June 28, 2018Read more
Leafly spoke with VP Stephen Schultz about the significance of FDA approval, when Epidiolex might become available to patients, and what’s coming next from the drugmaker.
Spicer Sends Cannabis Stocks Into Trump SlumpLisa Rough - Published on February 27, 2017Read more
The repercussions from Trump administration comments continue to echo through the cannabis industry.
How GW Pharma Could Use US Patents to Shape the Future of Medical CannabisBruce Barcott - Published on March 16, 2016Read more
After its success with epilepsy drug Epidiolex, the British company is patenting drugs to treat cancer, epilepsy, diabetes — even constipation.
3 Facts About Cannabis, Obesity, and DiabetesAnna Wilcox - Published on December 12, 2013Read more
New studies are finding that cannabis may be key to controlling diabetes. Multiple studies have found a correlation between cannabis, weight control, and potential diabetes treatments.